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Summary
Mature recirculating B cells are generally assumed to
exist in follicular niches in secondary lymphoid or-
gans, and these cells mediate T-dependent humoral
immune responses. We show here that a large pro-
portion of mature B lymphocytes occupy an anatomi-
cally and functionally distinct perisinusoidal niche in
the bone marrow. Perisinusoidal B cells circulate
freely, as revealed by parabiosis studies. However,
unlike their counterparts in the follicular niche, these
cells are capable of being activated in situ by blood-
borne microbes in a T-independent manner to gener-
ate specific IgM antibodies. The bone marrow repre-
sents a unique type of secondary lymphoid organ in
which mature B cells are strategically positioned in
the path of circulating microbes.
Introduction
The bone marrow is the primary site of B cell generation
after birth (Rajewsky, 1996; Nunez et al., 1996) and has
long been considered to be exclusively a primary lym-
phoid organ. Immature B cells leave the bone marrow
and mature in the spleen, primarily developing into ma-
ture follicular B cells. Recirculating CD23+ follicular B
cells include IgDhiIgMloCD21int and IgDhiIgMhiCD21int
cells (Waldschmidt et al., 1988; Hardy et al., 1983; Oliver
et al., 1997; Cariappa and Pillai, 2002; Pillai et al., 2005).
These cells recirculate freely, homing to B cell areas
or follicles in secondary lymphoid organs such as the
spleen, lymph nodes, and Peyer’s patches. A distinct,
smaller, specialized population of naive B cells in the
spleen resides in the vicinity of the marginal sinus
(Kraal, 1992). These marginal zone (MZ) B cells do not
recirculate, have a more restricted repertoire than follic-
ular B cells (Dammers et al., 2000), and are poised to
respond rapidly to blood-borne pathogens (Martin and
Kearney, 2000). MZ B cells, in conjunction with B-1 B cells
(that reside primarily in the peritoneum and mucosal
sites), are believed to be responsible for most T-inde-
pendent immune responses against multivalent antigens
and for the generation of natural antibodies (Martin et al.,
2001). MZ B cells, however, also possess the ability to
activate naive T cells and to contribute to T-dependent*Correspondence: pillai@helix.mgh.harvard.eduimmune responses (Song and Cerny, 2003; Attanavanich
and Kearney, 2004).
Although cells with a mature follicular phenotype
have long been observed in the bone marrow (Nunez
et al., 1996), the actual location of IgD+ B cells in the
bone marrow has never been determined. Specific
niches in which pro-B and pre-B cells develop have
been identified (Tokoyoda et al., 2004), and IgM+ B cells
have been detected in both the intravascular and extra-
vascular spaces of the bone marrow (Osmond and Bat-
ten, 1984; Hermans et al., 1989). It is unclear whether
mature IgD+ B cells reside extravascularly in this organ,
and it is not known whether the architectural equivalent
of a follicle exists in the bone marrow. From a functional
humoral immunity standpoint, some early studies sug-
gested that lymphocytes in the bone marrow may be
distinct from their counterparts in the spleen. When
bone marrow cells were transferred to recipient mice,
responses to a T-dependent antigen were observed
only when thoracic duct-derived cells or thymocytes
were transferred as well (Claman et al., 1966, 1969). In
short-term cell-transfer experiments, injected follicular
B cells derived from the spleen or lymph nodes have
been shown to home to the bone marrow (Berlin-Rufen-
ach et al., 1999), but it is unclear whether such cells
enter the extravascular space of the bone marrow and
remain in this compartment as a sessile population or
if they freely recirculate. A number of mutant mice with
enhanced BCR signaling have been described that
have markedly reduced numbers of mature bone mar-
row follicular B cells but normal or increased numbers
of splenic or lymph node IgDhiIgMlo mature follicular
B cells (Nishizumi et al., 1995; Otipoby et al., 1996;
O’Keefe et al., 1996; Pan et al., 1999; Cariappa et al.,
2001). In the case of CD22 null mice, it has been sug-
gested that CD22, apart from functioning as a negative
regulator of BCR signaling, might also serve an adhe-
sive function for the entry of B cells into the bone mar-
row (Floyd et al., 2000), but this has been disputed in
recent studies (Poe et al., 2004). The precise reason
why follicular phenotype B cells fail to accumulate in
the bone marrow in all these signaling mutants remains
to be established.
A number of specific questions therefore remain to
be answered about the normal physiology of mature
follicular phenotype B cells in the bone marrow. Do
these cells reside extravascularly? Do mature bone
marrow B cells recirculate freely, like all other follicular
phenotype B cells, or do they represent a sessile pop-
ulation? Are mature B cells in the bone marrow orga-
nized in follicle-like structures or B cell areas as they
are in all other secondary lymphoid organs? Given the
vascular nature of the bone marrow, do mature bone
marrow B cells respond to blood-borne microbes?
Earlier studies suggest that B and T cells derived from
the bone marrow do not collaborate with each other
after transfer into recipients; but given the existence in
the bone marrow of naive and activated T cells as well
(Khazaie et al., 1994; Tripp et al., 1997; Kuroda et al.,
2000; Masopust et al., 2001; Feuerer et al., 2003), do
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culating microbes in vivo either in collaboration with T
cells or in a T-independent manner?
Results
Mature B Cells in the Bone Marrow Represent
a Large Proportion of All B Cells with
an IgDhiCD21int Naive Follicular B Cell Phenotype
Bone marrow B lymphocytes with a follicular pheno-
type include IgDhiIgMloCD21int and IgDhiIgMhiCD21int B
cells. These bone marrow B cells are quite abundant,
adding up to a little over a fourth of all IgDhi B cells in
the spleen (Figure 1). This represents a much larger pool
of presumed naive B cells than that observed in the
blood, which indirectly suggests that bone marrow B
cells are located extravascularly (Figure 1). Newly
formed/Transitional Type 1 IgMhiIgDloCD21loCD24hi B
lymphocytes, which are generally not considered to be
recirculating B cells, can be observed both in the
spleen and the bone marrow (Figure 1). The newly
formed/T1-like population in the bone marrow may be
distinguished from Fraction E cells on the basis of its
expression of low levels of IgD; Fraction E B cells repre-
sent IgM-expressing cells in the bone marrow that do
not express detectable surface IgD (Figure 1).
Two-Photon Microscopy Reveals an Extravascular
Perisinusoidal Niche for Mature B Cells
in the Bone Marrow
A characteristic of secondary lymphoid organs is the
presence of defined B cell areas or follicles. Examining
the architecture of bone marrow lymphoid collections
poses some technological challenges. We transferred
CMTMR-labeled mature CD43− splenic B lymphocytes
into unirradiated recipient mice and examined bone
marrow cavities of the mouse calvarium using two-pho-
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iFigure 1. The Murine Bone Marrow Contains
a Large Number of IgDhi Cells
The contour graphs in the top panel compare
IgM- and/or IgD-expressing B cells in the bone
marrow, spleen, and blood. Numbers repre-
sent percentage of cells in each fraction. The
lower panel describes the phenotype of each
of the fractions and quantitates the absolute
numbers of mature B cells in the bone mar-
row and spleen; n = 22 mice for BM, n = 35
mice for spleen, and n = 4 for blood. See
Experimental Procedures for method of cal-
culating absolute numbers in total bone mar-
row and peripheral blood.on microscopy. In Figure 2, blood vessels were stained
sing FITC-Dextran (green), and B lymphocytes were
abeled with CMTMR (red). It is worth noting that the B
ells seen in the figure represent transferred cells only,
hich probably account for a small fraction of all the B
ells in the vicinity. It is clear from these studies that
ature bone marrow B cells exist in the extravascular
pace of the bone marrow (see Movie S1 in the Supple-
ental Data available with this article online) and are
rganized into circumscribed areas. Time-lapse im-
ging of these structures revealed that B lymphocytes
n the bone marrow occupy architecturally definable
iches contiguous with bone marrow sinusoids and
hat lymphocytes in one B cell area do not migrate into
second neighboring B cell cluster (Movie S2). These
ollections could be observed even 24 hr after transfer
s seen in Figure 2 (middle and right). These architec-
ural features suggest that the bone marrow, like other
econdary lymphoid organs, contains distinguishable B
ell areas, but in contrast to conventional follicles in
ther organs, B cells in the bone marrow are organized
round vascular sinusoids, positioning them, in a man-
er reminiscent to B cells of the splenic marginal zone,
n the path of blood-borne pathogens.
erisinusoidal B Cells Freely Enter
nd Leave the Bone Marrow
defining characteristic of all B cells with a follicular
henotype is that they are freely recirculating lympho-
ytes that reside in specialized B cell areas in second-
ry lymphoid organs. Follicular phenotype B cells seen
n the bone marrow have long been known as “recircu-
ating” B cells, but it has often been assumed that these
ells reside intravascularly in the bone marrow. To de-
ermine whether IgDhi B cells in the bone marrow circu-
ate freely, we examined parabiotic mice. An important
ssue to consider when examining parabiotic mice has
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399Figure 2. Organized Perisinusoidal Extravas-
cular B Cell Collections Are Observed in the
Bone Marrow by Two-Photon Microscopy
Visualization by multiphoton microscopy of
transferred mature splenic B cells in the
bone marrow of live nonirradiated recipient
mice, 2 hr (left) and 24 hr (middle and right)
after transfer. Arrows point to cell clusters
and arrowheads to sinusoids (see Movies S1
and S2).been raised by the demonstration that about 3–5 days
after mice are united, hematopoietic stem cells cross
from one partner to another (Wright et al., 2001). Most
parabiotic studies on lymphocyte populations have in-
volved the examination of mice many weeks after they
have been united. By this time, progenitors might have
crossed over from one mouse to its partner and ma-
tured, potentially leading to erroneous assumptions
about recirculating populations. MZ B cells, for in-
stance, are observed only in the spleen in rodents, and
these are recognized to be nonrecirculating B cells
(Gray et al., 1982). However, MZ B cells derived from
one partner of a parabiotic pair can be identified after
several weeks in the other partner in reasonably large
numbers (Figure 3A, bottom). Such a result may well
represent the generation of MZ B cells in this mouse
from newly formed or other transitional B cells that
have crossed from one mouse to the other and have
subsequently matured into MZ B cells. To address the
issue of recirculation satisfactorily, we examined para-
biotic pairs at a number of time points. Congenic inbred
mice differing at the Ly5 locus (CD45.1 versus CD45.2)
and mice that express E-GFP paired with nontrans-
genic partners were examined in these experiments.
Pro-B cells are restricted to the bone marrow in adult
mice (Rolink et al., 1993). An examination of CD45int
CD43int pro-B cells (Figure 3B) revealed that as early as
7 days after union, pro-B cells of CD45.1 origin begin
seeding the bone marrow of the CD45.2 counterpart. A
similar result was seen with EGFP-expressing mice and
their partners. It is clear that if one were to examine
parabiotic partners in the first 2 weeks after union, a
small fraction of cells would appear to have crossed
over—far below the roughly equivalent numbers of cells
that we would expect to observe if cells freely recircu-
late. The apparent transfer of pro-B cells and MZ B
cells may therefore be ascribed to the crossing over
and subsequent maturation of small numbers of hemato-
poietic stem cells or of other progenitor cells and does
not reflect true recirculation.
In stark contrast, examination of splenic and bone
marrow IgDhi B cells in timed parabiotic experiments
revealed that within 9–14 days after union, approxi-
mately 50% of these cells were derived from the parabi-
osed partner (Figure 3C). These results indicate that
perisinusoidal B cells have free access to the circula-
tion. They strongly suggest, as discussed further below,
that IgDhi B cells in the bone marrow, like their counter-
parts in well-established secondary lymphoid organs,
are freely recirculating cells. Parabiosis studies per-formed in parallel on T cells in the thymus, spleen, and
bone marrow reveal that while mature CD4+ and CD8+
T cells can recirculate freely between the spleen and
bone marrow, they do not home to the thymus (Figure
S1). In contrast to B cells in the bone marrow, mature
T cells do not return to the thymus after attaining matu-
rity in the periphery.
A recirculating lymphocyte enters a secondary lym-
phoid organ in search of antigen and then, in the ab-
sence of specific antigen, leaves for other secondary
lymphoid organs. While our two-photon experiments
establish that B cells rapidly enter the bone marrow,
direct evidence has not been provided that they leave
this site. The most direct interpretation of our parabio-
sis experiments is to infer that mature B cells must con-
stantly emerge from the bone marrow apart from enter-
ing it from the blood, in order for equivalence of bone
marrow B cells from both partners to be achieved.
However, it is formally possible that mature B cells en-
ter from the blood and never leave the bone marrow,
but turn over rapidly in this organ and therefore need
to be constantly replenished. This sort of rapid replen-
ishment from the circulation could also, in theory, lead
to the equivalent distribution of mature B cells from
host- and partner-derived populations in parabiosis ex-
periments. In order to address this possibility, we have
used BrdU labeling and decay, over a 7 week period,
to compare the life spans of mature B cells in the bone
marrow and the spleen. As seen in Figure 3D, IgDhiIgMlo
B cells in both the bone marrow and the spleen are
long lived and appear to turn over with almost identical
kinetics. Mature B cells in the bone marrow therefore
are not a short-lived population that needs to be rapidly
replenished. Taken together with this turnover data, our
parabiosis results strongly support the view that mature
bone marrow B cells are part of a larger pool of recircu-
lating mature B cells.
Activated B Cells Are Induced in the Bone Marrow
by Blood-Borne Microbes
Although the bone marrow functions as a primary lym-
phoid organ, it may also potentially serve as a second-
ary lymphoid organ for the induction of humoral immu-
nity. Given the vascularity of the bone marrow and the
strategic location of perisinusoidal B cells, we consid-
ered the possibility that these B cells might be acti-
vated by blood-borne microbes, particularly microbes
with a known propensity for the bone marrow. In order
to further establish that the bone marrow is functionally
a secondary lymphoid organ, we challenged mice intra-
Immunity
400Figure 3. Follicular Phenotype B Cells in the Spleen and Bone Marrow Recirculate Freely
(A) Limited mobilization of MZ B cells was noted early after parabiotic union of CD45.1 and CD45.2 congenic inbred partners. After extended
periods of parabiosis, significant mobilization was noted that persisted even after separation (bottom).
(B) Limited mobilization of pro-B cells was noted early after union. Studies were performed both with CD45.1/CD45.2 partners and EGFP/
nontransgenic partners.
(C) Rapid mobilization to equivalence of IgDhi populations in bone marrow and spleen occurs early after parabiotic union of CD45.1 and
CD45.2 congenic inbred partners. Each time point represents a pair of mice, and numbers reflect the percentage of cells within the gate.
(D) BrdU labeling and decay studies reveal that bone marrow and splenic IgDhiIgMlo B cells have similar life spans.venously with a vaccine strain of Salmonella typhimu-
rium (Hormaeche et al., 1996). We noted that intrave-
nously injected S. typhimurium accesses the spleen
and bone marrow but does not readily access lymph
nodes (Table 1). In wild-type mice, S. typhimurium was
cultured from the spleen (colony forming unit [cfu]
range 42–138/106 cells) and bone marrow (5–21 cfus/
106 cells) within the first 2 days after intravenous injec-
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Bone Marrow, and Lymph Nodes 2 Days after Injection
Absolute Number of Colony-Forming Units
in Total Organ
Spleen Bone Marrow Mesenteric LN
Mouse 1a 10,600 11,236 0
Mouse 2a 3,700 2,226 0
SL3261 vaccine strain, 1 x 106 injected intravenously.
a C57BL/6.
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mion. The bacterium was not found in mesenteric lymph
odes (0 cfus; the assay has a detection limit of 2 cfus).
In order to establish that perisinusoidal B cells do
espond in situ to microbes, we decided to look for ac-
ivated B cells in the bone marrow itself, very soon
fter microbial challenge. It is now recognized that many
-independent responses can result in the formation of
cell clusters made up of activated CD45+PNA+ B cells
Manser, 2004), although cells with these phenotypes
re more frequently described in germinal centers dur-
ng T-dependent immune responses. As seen in Figure
A (left), as early as 2 days after exposure to S. typhi-
urium, CD45R+PNA+ B cells (Kraal et al., 1982; Shinall
t al., 2000) were as abundant in the bone marrow as
hey were in the spleen. At the very earliest time that
e could observe activated B cells in the spleen (1 day
fter microbial challenge, see Figure 4C), identical cells
ere also prominent in the bone marrow. The extreme
apidity with which such cells are observed in the bone
arrow provides a convincing case for the contempo-
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401Figure 4. Activated Bone Marrow B Cells Are
Generated after Exposure to Blood-Borne
Microbes, but These Cells Do Not Induce the
Expression of AID
(A) CD45R+PNA+-activated B cells are seen
both in the bone marrow (BM) and spleen
(Sp) as early as two days after intravenous
challenge with SL3261, a vaccine strain of Sal-
monella typhimurium (left). These cells are
also Fashi (CD95+, right). Numbers represent
percentage of double-positive cells in each
gate. The contour plots shown are a repre-
sentative example of data obtained from six
mice. Bone marrow and spleen data shown
in tandem in this and every other figure are
from the same animal.
(B) The activated B cell response in the bone
marrow following intravenous Salmonella ty-
phimurium SL3261 injection is not depen-
dent on TLR4. Contour plots are representa-
tive of three mice in each group. Numbers
represent percentage of CD95+/PNA+ double-
positive cells in each gate.
(C) Sorted CD45R+PNA+ B cells in the spleen
but not in the bone marrow express AID RNA
as early as day 1 after microbial challenge.
RT-PCR products were separated on a 1.5%
agarose gel. The AID PCR product is 348 bp
in length, and the HPRT product is 248 bp
long. RT−, no reverse transcriptase; S, sham;
T, test; M, marker. Each lane represents an
analysis from a single mouse, and the results
shown are representative of three mice per
time point.
(D) AID is not induced in activated bone mar-
row B cells after either a primary or second-
ary microbial challenge. Mice were immu-
nized on day 0 and day 11, and sorted
CD45R+PNA+ cells from individual mice were
subjected to RT-PCR analysis. Each lane
represents an individual analysis from a sin-
gle mouse. Two mice were analyzed per time
point. See legend to Figure 4C for details.raneous in situ generation of activated B cells in the
bone marrow and spleen. These activated PNA+ B cells
express Fas (CD95, Figure 4A, right) at levels compara-
ble to those of germinal center phenotype B cells (Shi-
nall et al., 2000). Similar activated B cells were not ob-
served when mice were injected intraperitoneally (data
not shown). Although S. typhimurium expresses high
levels of LPS on the surface, these activated B cells
were generated largely in a TLR4-independent manner
(Figure 4B).
AID Is Rapidly Induced in the Spleen
but Not in the Bone Marrow
Activation-induced cytidine deaminase (AID) was in-
duced in splenic PNA+ B cells as early as 1 day after
microbial challenge (Figure 4C). It was never observedin any of the PNA+ B cells in the bone marrow, even
after a second challenge with intravenous attenuated
S. typhimurium (Figure 4D). The studies of Claman (Cla-
man et al., 1966, 1969) have long suggested that B cells
in the bone marrow require T cells from some other
source in order to generate T-dependent immune re-
sponses in recipients of adoptive transfers. Although
the bone marrow does contain CD4+ T cells, little is
known regarding the organization or function of these
cells.
Activated B Cells Are Induced in the Bone Marrow
in the Absence of T Cells
In order to more conclusively establish whether acti-
vated B cells can be induced in the bone marrow in
the absence of all T cells, we examined TCRβ/δ double
Immunity
402Figure 5. Activated B Cells Are Observed in the Bone Marrow in the
Absence of T Cells and of the Spleen
(A) After exposure to blood-borne SL3261, activated bone marrow
B cells are observed in the complete absence of T cells. Contour
plots are from a representative analysis. There were three mice in
each of the test groups.
(B) Activated B cells are found in the BM of immunized mice in the
absence of the spleen. Splenectomized mice were injected intrave-
nously with a vaccine strain of S. typhimurium, and the bone mar-
row was analyzed after 2 days. Contour plot from the splenecto-
mized test mouse is representative of five mice from two separate
experiments.
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Wknockout homozygotes (Figure 5A) that lack all T cell
populations. Activated B cells were readily observed,
albeit to a slightly lesser extent in the bone marrow, in
the absence of any T cells, indicating that perisinusoi-
dal B cells may be activated even in the absence of T
cell help. The possibility that T cells can also contribute
to B cell activation in the bone marrow cannot be ex-
cluded. The activated B cell phenotype seen on flow
cytometry in the bone marrow is consistent with the
activation phenomenon that is observed in responses
to some T-independent antigens, in the absence of
concomitant isotype switching and somatic mutation
(Manser, 2004). Perisinusoidal B cells in the bone mar-
row may be uniquely situated to encounter and re-
spond to certain blood-borne pathogens that tend to
enter and colonize this compartment.
We wished to establish that the activated B cells
seen were generated in situ and did not represent cells
that had migrated from the spleen to the bone marrow.
We considered examining the bone marrows of sple-
nectomized Aly mice (which lack NIK, an NFκB-activa-
ting kinase). These mice lack lymph nodes but are not
suitable for our studies because B cells that lack NIK
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nannot be readily activated (Yamada et al., 2000). We
herefore splenectomized wild-type mice and chal-
enged them intravenously with the vaccine strain of
. typhimurium. As can be seen in Figure 5B, bone mar-
ow B cells were readily activated in mice whose
pleens had been removed. These data suggest that
lood-borne microbes may induce the activation of B
ells in the bone marrow and that this activation almost
ertainly represents an in situ response.
We wished to ask whether the CD45R+PNA+ B cell
opulation that we observed in the bone marrow was
erived from mature bone marrow B cells as we pre-
umed or whether it represented some aberrant activa-
ion of pro-B or pre-B cells. PNA+ germinal center B
ells are known to downregulate surface Ig and express
elatively low levels of κ or λ light chains. Pro-B and
re-B cells tend to express low levels of CD45R and do
ot express conventional surface κ or λ light chains.
n vaccinated bone marrow, CD45R+PNA+ B cells (red)
xpress low levels of κ light chains (Figure S2). These
evels are indistinguishable from the levels of surface κ
n the majority of splenic CD45R+PNA+ germinal center
cells in vaccinated mice (pink). CD45R−PNA− cells
orange dotted line) represent non-B cells in the bone
arrow, and these cells do not express κ light chains.
he CD45RloPNA− cell pool (green) includes most pro
nd pre-B cells as well as a proportion of Fraction E
mmature B cells. The majority of these cells, as ex-
ected, do not express detectable κ light chains. The
D45RhiPNA− population (blue) includes mature B cells,
ost of which express κ light chains, and the propor-
ion that do not have presumably rearranged and ex-
ress λ light chains. These data indicate that most, if
ot all, CD45R+PNA+ B cells in the bone marrow origi-
ate from mature B cells and not from precursors.
ctivated B Cell Populations in the Bone Marrow
an Contribute to Serum IgM in Recipient
ag-1 Null Mice
e performed cell-transfer studies in order to deter-
ine whether the PNA+ B cells that we observe in the
one marrow are functional collections of activated B
ells. Mice were intravenously injected with the vaccine
train of S. typhimurium, and 2 days later CD45R+PNA+
cells were purified from both the bone marrow and
he spleen. 3 × 105 activated bone marrow B cells
ere injected into each of two unirradiated recipient
ag-1 null mice, and similar transfers were performed
ith CD45R+PNA+ B cells from the spleen. 1 week later,
ecipient mice were bled, and serum IgM levels were
ssayed in recipient mice and in Rag-1 null controls.
As seen in Figure 6, transferred activated B cells from
oth spleen and bone marrow contribute to the genera-
ion of serum IgM in Rag-1 null recipients. This sug-
ests that the activated B cell population in the bone
arrow, like its counterpart population in the spleen, is
functional population that is capable of differentiating
nto IgM AFCs in vivo.
While similar numbers of CD45R+PNA+ B cells de-
ived from bone marrow and spleen were transferred
nto Rag-1−/− recipients, the levels of IgM observed af-
er 1 week were higher in mice that had received sple-
ic CD45R+PNA+ B cells. The reason for this difference
Perisinusoidal B Cells and T-Independent Responses
403Figure 6. Activated Bone Marrow B Cells Contribute to IgM Secre-
tion in Rag-1-Deficient Recipients
CD45R+PNA+ B cells were flow purified from the bone marrow and
spleens of C57Bl/6 mice that had been injected 48 hr earlier with
SL3261 cells. 3 × 105 sorted B cells from the bone marrow were
transferred into each of two Rag-1−/− recipients that had not been
irradiated. In parallel, similar transfers were made of spleen-derived
CD45R+ PNA+ B cells into two Rag-1−/− recipients. Total IgM levels
were estimated using an ELISA approach. Error bars represent
±SEM of quadruplicate wells for each of two serum samples.is not known at present, though it might be speculated
that T-dependent germinal center phenotype B cells
(from the spleen) survive better than their bone marrow
counterparts that might have been activated in a T-inde-
pendent manner.
T-Independent Induction of IgM AFCs
in the Bone Marrow
Our studies have established that activated B cells may
be generated in the bone marrow in response to intra-
venous injection of S. typhimurium and that this activa-
tion event occurs in splenectomized mice in the ab-
sence of T cells. While these activated B cells are
capable of quite rapidly contributing to IgM secretion
in recipient mice, we also wished to establish whether
anti-Salmonella IgM-secreting antibody-forming cells
were generated in the bone marrow following vacci-
nation.
We used an ELISPOT approach to identify antibody-
forming cells that secrete anti-Salmonella IgM anti-
bodies, in both the spleen and the bone marrow, in
wild-type mice before and after splenectomy and in
TCRβ/δ double knockout homozygotes. Since blood-
borne S. typhmiurium lodges preferentially in the
spleen and bone marrow (Table 1), we also chose to
examine bone marrow anti-Salmonella IgM antibody
secretion in wild-type mice after splenectomy, in order
to rule out migration of activated B cells from theFigure 7. IgM Antibody-Forming Cells Are Generated in the Bone
Marrow in Response to Blood-Borne Microbes
Control mice and animals whose spleens were removed were im-
munized with the vaccine strain of S. typhimurium and ELISPOT
assays were performed for Salmonella-specific AFCs (left). Control
and T cell-deficient mice were also analyzed (right, error bars ±
SEM of sextuplicate wells in left panel, and triplicate wells in right
panel, three mice in each group). p values were determined using
the Mann-Whitney U test, and in general compare test samples
with their respective shams. In the right panel, a p value was also
provided for the comparison between a T cell-deficient sham and
a wild-type sham.spleen. As can be seen in Figure 7 (left), IgM-secreting
antibody-forming cells were generated in the bone mar-
row soon after exposure to a blood-borne microbe, and
the spleen was not required for this response. Although
in TCRβ/δ double knockout homozygotes (that lack all
T cells) there appear to be increased levels of anti-Sal-
monella IgM-secreting plasma cells even in the ab-
sence of vaccination, similar numbers of antibody-
forming cells were observed in wild-type and TCR null
mice after vaccination (Figure 7, right). These studies
indicate that apart from MZ and B-1 B cells, IgDhi B
cells in their perisinusoidal habitat may also represent
an important source of IgM-secreting plasma cells.
Discussion
Our studies reveal that mature B cells in the bone mar-
row are located in a perisinusoidal niche. Parabiosis
studies, in conjunction with the demonstration that
these B cells are as long-lived as their counterparts in
other organs, strongly suggest that these cells repre-
sent recirculating B cells. Mature B cells in the bone
marrow have access to the circulatory system and freely
enter and exit the bone marrow. It is formally possible
that there are two distinct types of mature IgDhiIgMlo
B cells that can enter the circulation, one that moves
from one bone marrow cavity to another via the blood
stream but does not enter secondary lymphoid organs,
and another that never enters the bone marrow but re-
circulates, entering and exiting all conventional sec-
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404ondary lymphoid organs. IgDhiIgMlo B cells from the
bone marrow and from the spleen turn over in a virtually
identical fashion and appear to be phenotypically sim-
ilar. Although the inability to induce AID in activated
bone marrow B cells (but not in the spleen) might sug-
gest that splenic and bone marrow B cells are intrinsi-
cally distinct, we suspect that this failure reflects differ-
ences in the lymphoid architecture of the bone marrow,
or possibly a relative abundance of regulatory T cells
at this site. These issues remain to be examined.
The fact that mature B cells from the spleen can read-
ily enter the extravascular spaces of the bone marrow
argues against a dichotomy in homing characteristics.
The available evidence lends support to the view that
recirculating B cells not only visit the spleen, lymph
nodes, and Peyer’s patches, but also enter and exit the
bone marrow, where they occupy a unique and distinct
niche. Nevertheless, to further examine this issue, fu-
ture studies will address whether lymph node-derived
IgDhi B cells transferred into congenic recipients are
distributed in an equivalent fashion in spleen and
bone marrow.
B cell collections that anatomically resemble conven-
tional germinal centers have been described in second-
ary lymphoid organs after immunization with T-indepen-
dent Type 2 antigens (Wang et al., 1994; Lentz and
Manser, 2001). These T-independent germinal center-
like B cell clusters are not linked to Ig class switching
and somatic mutation. We have shown here that chal-
lenge with a blood-borne microbe results in the accu-
mulation of B cells in the bone marrow with surface
characteristics that resemble those of germinal center
B cells. These cells accumulate in the absence of T cells
and of the spleen. They are functional as evidenced by
their ability to induce IgM secretion, presumably after dif-
ferentiation into IgM AFCs, in Rag-1−/− recipients.
We recognize that we have not excluded with com-
plete certainty the possibility that even though intrave-
nously injected S. typhimurium cannot be cultured from
lymph nodes or from the peritoneum, nonetheless B
cells may be activated at these sites and then migrate
to the bone marrow. While class-switched germinal
center-derived memory B cells and plasma cells have
been described in the blood as early as 6 days after
primary immunization (Blink et al., 2005), there is no evi-
dence that PNA+ B cells or IgM AFCs can migrate from
secondary lymphoid organs to the bone marrow. More-
over, PNA+ B cells are observed in the bone marrow in
our studies as early as 1 day after vaccination, and IgM
AFCs have been seen in this organ soon after. Strong
evidence connecting the activated B cells in the bone
marrow to IgM AFC generation in this organ is still lack-
ing. Immunization was performed with live microbes,
and a microbial lysate was used in the ELISPOT assays.
The heterogeneous and relatively crude nature of the
antigen used does not lend itself to quantitative fre-
quency analyses, which could potentially provide a
more convincing link between the PNAhi population and
IgM AFC generation. Studies using antigen-specific
BCR knockin mice specific for a well-defined microbial
antigen may provide more direct evidence in this re-
gard. We nevertheless believe that it is reasonable to
conclude that in splenectomized mice exposed to
blood-borne microbes, activated B cells in the bone
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he precursors of IgM AFCs found at this site.
It has previously been suggested that the bone mar-
ow is an important site for cytotoxic T cell activation
nd memory T cell generation (Khazaie et al., 1994;
ripp et al., 1997; Kuroda et al., 2000; Masopust et al.,
001; Feuerer et al., 2003). Our studies suggest that the
one marrow is a functional site for B cell responses.
his primary lymphoid organ can be said to meet the
rchitectural, recirculatory, and functional requirements
o be categorized as a dual primary and secondary lym-
hoid organ for humoral immune responses. This study
omplements previous studies demonstrating that stem
ells, progenitor B cells, and plasma cells occupy stage-
pecific niches in the bone marrow (Calvi et al., 2003;
ermans et al., 1989; Tokoyoda et al., 2004).
It is generally assumed that T-independent immune
esponses are the domain of MZ B cell and B-1 B cells
hile follicular B cells primarily mediate T-dependent
mmune responses (McHeyzer-Williams, 2003). How-
ver, our studies suggest that mature B cells have two
unctionally distinct habitats. In canonical follicles suited
or T-B interactions such as those found in the spleen
nd lymph nodes, follicular B cells are capable of par-
icipating in T-dependent responses. The same cells,
hen they arrive at, or are generated in, perisinusoidal
one marrow areas, are apparently specialized for
-independent responses to blood-borne antigens. In a
revious study, antibody-forming cells were described
n the bone marrow of splenectomized mice following
mmunization with a synthetic T-independent Type I an-
igen (Koch et al., 1982). These responses were pre-
umably initiated by what we now recognize as follicu-
ar phenotype B cells in the perisinusoidal niche. MZ B
ells in the spleen are also located around a vascular
inus (Kraal, 1992), but the repertoires of MZ B cells
nd FO B cells are believed to be distinct (Dammers et
l., 2000). These two populations of B cells in the
pleen and bone marrow may play complementary
oles in responses to blood-borne pathogens.
xperimental Procedures
ice
- to 12-week-old BALB/c, C57BL/6 (CD45.2), B6.SJL (CD45.1),
57BL/6-TgN (ACTbEGFP)1Osb, C3H/HeOUJ, C3H/HeJ, and B6.
29S7-Rag1 mice from the Jackson Laboratories (Bar Harbor, ME)
nd the Charles River Laboratories (Wilmington, MA) were used in
his study. β/δ−/− mice were a generous gift from Dr. Atsushi Mizo-
uchi. Animal procedures were cleared by the subcommittees on
esearch animal care at MGH and at the Center for Blood Research.
ntibodies, Staining, and Flow Cytometry
he murine monoclonal antibody conjugates used have been listed
lsewhere (Cariappa et al., 1999, 2001) except for the following:
ITC-A20 (anti-CD45.1, mouse A.SW IgG2a, κ), FITC-104 (anti-CD45.2,
ouse (SJL) IgG2a, κ), PE-GK1.5 (anti-CD4, rat IgG2b, κ), APC-53-
.7 (anti-CD8a, rat IgG2a, κ), and BI-J2 (anti-CD95, hamster IgG)
all from BD-Pharmingen), goat anti-mouse kappa (κ chain specific;
outhern Biotech), and FITC-Peanut Agglutinin (PNA, Vector Labs).
iotinylated antibodies were revealed by streptavidin-fluorochrome
onjugates (also from BD-Pharmingen).
Flow cytometry was performed as described elsewhere (Cari-
ppa et al., 1999, 2001, 2005). Intracellular staining, to detect BrdU
Perisinusoidal B Cells and T-Independent Responses
405incorporated into DNA, was performed as described earlier (Cari-
appa et al., 1999).
The cytometers and sorters used were Epics Elite ESP (Coulter
Corp.), FC500 and Epics Altra hyper-sort system (both Beckman
Coulter Corp.), MoFlo (DakoCytomation), and FACSAria (Beckton,
Dickinson). The purity of sorted samples always exceeded 96%.
Gates in the spleen were set according to Hardy (Hardy et al.,
1983), and the gates in the bone marrow were set according to
Hardy (Hardy et al., 1991) and Hendriks (Hendriks et al., 1996). Pro-
cessed samples were analyzed using FloJo v6.3.1 (Treestar Inc.)
analysis software.
Two-Photon Microscopy
Detailed methodology is described elsewhere (Mazo et al., 2005).
C57BL/6 mice were injected with 55–65 × 106 CD43− (Wells et al.,
1994) syngeneic splenic B cells purified using CD43+ immunomag-
netic beads (Miltenyi Biotech GmbH), and labeled with 10 M of 5-
(and -6)-(((4-chloromethyl) benzoyl) amino) tetramethylrhodamine
(CMTMR). High molecular weight (2MD) FITC-dextran was injected
prior to cell injection to contrast BM vessels.
Surgical Procedures
Parabiosis was performed as described (Bunster and Meyer, 1933).
C57BL/6 (CD45.2) mice were united to B6.SJL (CD45.1) mice, and
C57BL/6-TgN (ACTβEGFP)1Osb were united with C57BL/6 mice.
Parabiosis was well tolerated, and the mice were active over the
period of study. Splenectomy was performed following standard
surgical procedures.
Bromodeoxyuridine Labeling and Chase
Continuous labeling with BrdU was performed as described earlier
(Cariappa et al., 1999).
Bacterial Challenge Studies
0.5 × 106 bacteria derived from an overnight culture of S. typhimu-
rium strain SL3261 (Hormaeche et al., 1996) were injected intrave-
nously into mice housed in a BL2 facility. For determination of col-
ony-forming units, bone marrow, splenic, and lymph node cells
were lysed in sterile 1% Triton X-100. Serial dilutions of the lysates
were made in PBS and plated on LB agar. Colonies were counted
after overnight incubation at 37°C and the number of cfu per million
cells calculated. For organ colony counts, the same procedure was
used after creating single-cell suspensions.
RT-PCR
Standard methods were used to prepare total cellular RNA and
first-strand cDNA from flow-purified cells. The following primers
(5#-3#, forward followed by reverse) were used in the PCR: hypo-
xanthine guanine phosphoribosyltransferase (HPRT), GCTGGTGAA
AAGGACCTCT and CACAGGACTAGAACACCTGC; and activation-
induced cytidine deaminase (AID), GAGGGAGTCAAGAAAGTCACGC
and GGCTGAGGTTAGGGTTCCATCT. The AID primer sequences were
adapted from previously published reports (Muramatsu et al., 1999).
Activated B Cell Transfer into Rag-1 Null Mice
C57BL/6 mice were injected with SL3261 as described above. 2
days later, splenocytes and bone marrow from a pool of six mice
were collected, stained with CD45R-PE and PNA-FITC, and flow
purified for CD45R+PNA+ B cells. 3 × 105 CD45R+PNA+ B cells were
injected into nonirradiated Rag-1−/− mice via the tail vein. Each
Rag-1 mutant received either splenic or BM B cells. 7 days later,
peripheral blood was collected and serum separated for ELISA.
IgM Capture ELISA
Standard methodology was used. The capture antibody was puri-
fied goat anti-mouse IgM (Caltag Laboratories), and the revealing
antibody was goat anti-mouse IgM conjugated to horseradish per-
oxidase (Southern Biotech). Sera diluted 1:10 and 1:100 were
plated in quadruplicate. The substrate was ABTS (2,2-azino-di(3-
ethylbenzthiazoline) sulfonic acid; Zymed Laboratories). OD was
measured at 405 nm in a Vmax Kinetic microplate reader (Molecu-
lar Devices).ELISPOT Assays
Published methodology was used (Szczepanik et al., 2003) with
slight modifications (Cariappa et al., 2005). Sonicated SL3261 (50
g/ml) was used to coat the wells of the filtration plate.
Determination of Absolute Numbers of Cells
in Bone Marrow and Blood
For calculation of absolute numbers in total bone marrow, we
multiplied the number of lymphoid cells in the selected gate, from
one femur and tibia, by a coefficient of 10.6, since 59Fe distribution
studies by Chervenick et al. (1968) have shown that 9.4% of total
mouse bone marrow is found in a femur and tibia combined. In our
hands, the average total count of nucleated cells from one set of
limb bones was 17 × 106.
Absolute numbers of circulating peripheral blood mononuclear
cells in the entire mouse was determined to be 4.8 × 106 based on
an average total PBMC count of 3.2 × 106 and a total blood volume
of 1.5 ml in a mouse weighing 20 g. This absolute PBMC value was
used to calculate absolute numbers in each of the peripheral blood
B cell fractions.
Curve Fitting
For the BrdU decay data points, curves of best fit by the least
squares method were generated using MacCurveFit 1.5 (Kevin
Raner Software, Australia).
Statistical Analysis
p values for differences between groups was determined by the
Mann-Whitney U test using StatView version 5.0.1.
Supplemental Data
Supplemental Data include two figures and two movies and can
be found with this article online at http://www.immunity.com/cgi/
content/full/23/4/397/DC1/.
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